Startseite Crystal structure of 4-methoxyphenyl-3-phenylpropiolate, C16H12O3
Artikel Open Access

Crystal structure of 4-methoxyphenyl-3-phenylpropiolate, C16H12O3

  • Jun Pan , Guo-Kai Jia , Fang Liu , Xiao-Ming Chen und Xing-Yu Zhang EMAIL logo
Veröffentlicht/Copyright: 9. September 2019

Abstract

C16H12O3, orthorhombic, Pbca (no. 19), a = 3.9935(16) Å, b = 16.629(7) Å, c = 19.406(8) Å, V = 1288.7(9) Å3, Z = 4, Rgt(F) = 0.0387, wRref(F2) = 0.1084, T = 296(2) K.

CCDC no.: 1935386
Figure 1: The structure of the title compound showing 40% probability displacement ellipsoids and the atom-numbering scheme.
Figure 1:

The structure of the title compound showing 40% probability displacement ellipsoids and the atom-numbering scheme.

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.32 × 0.28 × 0.24 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.09 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:27.5°, >99%
N(hkl)measured, N(hkl)unique, Rint:14445, 2930, 0.046
Criterion for Iobs, N(hkl)gt:I > 2s(I), 2342
N(param)refined:173
Programs:Bruker [1], SHELX [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.0581(5)0.45567(9)0.71069(8)0.0831(6)
O20.3362(5)0.47637(9)0.61209(7)0.0693(5)
O30.3527(4)0.80804(9)0.61734(8)0.0717(5)
C10.2742(6)0.16495(12)0.54743(10)0.0564(5)
H10.3642330.2005260.5154310.068*
C20.2484(6)0.08498(13)0.53169(11)0.0654(6)
H20.3219960.0663730.4891060.078*
C30.1146(7)0.03219(14)0.57838(12)0.0695(7)
H30.094768−0.0219680.5671500.083*
C40.0102(6)0.05892(13)0.64145(12)0.0681(6)
H4−0.0752340.0226720.6734340.082*
C50.0310(5)0.13927(13)0.65771(10)0.0585(5)
H5−0.0459320.1574530.7001780.070*
C60.1665(5)0.19318(11)0.61096(9)0.0492(4)
C70.1872(6)0.27691(12)0.62753(10)0.0569(5)
C80.1999(6)0.34677(12)0.64120(11)0.0641(6)
C90.1870(6)0.43072(12)0.65996(10)0.0582(5)
C100.3325(6)0.56091(12)0.61879(10)0.0546(5)
C110.2015(6)0.60363(14)0.56481(10)0.0600(5)
H60.1074680.5768650.5274530.072*
C120.2098(6)0.68617(13)0.56611(10)0.0609(5)
H70.1189520.7154200.5297940.073*
C130.3528(5)0.72575(12)0.62125(10)0.0521(5)
C140.4847(6)0.68230(12)0.67511(10)0.0549(5)
H80.5802320.7088970.7123970.066*
C150.4755(6)0.59918(12)0.67399(10)0.0555(5)
H90.5652330.5696100.7102360.067*
C160.5085(7)0.85106(13)0.67193(14)0.0819(7)
H100.4999090.9076620.6623370.123*
H110.7377650.8343780.6760020.123*
H120.3929820.8402010.7143000.123*

Source of material

A 25 mL Schlenk tube was charged with phenylpropiolic acid (1.0 mmol), p-methoxyphenol (1.2 mmol), dimethylaminopyridine (0.5 eq), dicyclohexylcarbodiimide (1.5 eq) in 10 mL of dichloromethane step by step. The reaction mixture was stirred at room temperature for 24 h. Upon the reaction completion (monitored by TLC), the reaction mixture was filtered, quenched with 5 mL of water, extracted with EtOAc (5 mL), washed with brine. The combined organic layers were dried over anhydrous Na2SO4, filtered, concentrated in vacuo and the residue was purified by chromatography on silica gel, using Hexane/EtOAc (10:1) as the eluent, give the 4-methoxyphenyl 3-phenylpropiolate as a colorless solid. The solid was dissolved in ethylene acetate and crystals of the title compound were obtained by slow evaporation within a week.

Experimental details

Hydrogen atoms were placed in their geometrically idealized positions and constrained to ride on their parent atoms.

Comment

In recent decades, thousands of alkynyl-containing active ingredients have been isolated from traditional medicinal plants or other active organisms [3], [4]. These alkynyl-containing active ingredients exhibit abundant biological activities, such as anti-tumor [5], anti-inflammatory [6], antibacterial, anti-viral, etc [7], [8]. Acetylenic acid ester compounds as reactants in organic synthesis, in the core skeleton structure of conjugated structures has an important position [9]. Therefore, it is important to find a highly efficient and simple synthetic protokol of conjugated olefin derivatives for the supplement of active compounds [10].

There is one molecule in the asymmetric unit of the title structure (see the figure). The single crystal structure verifies that all bond lengths are in normal ranges and in accord with parameters reported in the literature [11], [12].

Funding source: Hunan University of Science and Engineering

Award Identifier / Grant number: XNZW16C07

Funding source: The plant of Yongzhou Science and Technology innovation guidance program

Award Identifier / Grant number: 2018ZD16

Funding source: Research Programs of Hunan University of Science and Engineering

Award Identifier / Grant number: 17XKY015

Funding statement: The work was supported by the opening project of key laboratory of comprehensive utilization of advantage plants resources in Hunan south, Hunan University of Science and Engineering (XNZW16C07), The plant of Yongzhou Science and Technology innovation guidance program (2018ZD16), Research Programs of Hunan University of Science and Engineering (17XKY015).

References

1. Bruker. APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, WI, USA (2009).Suche in Google Scholar

2. Sheldrick, G. M.: SHELXT-integrated space-group and crystal-structure determination. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053273314026370Suche in Google Scholar

3. Aline, B.; Annie, L.; Arnaud, H.: Alkynylation of chiral aldehydes: alkoxy-, amino-, and thio-substituted aldehydes. Chem. Rev. 106 (2006) 2355–2403.10.1021/cr0509915Suche in Google Scholar

4. Alanko, J.; Kurahashi, Y.; Yoshimoto, T.: Panaxynol, apolyacetylene compound isolated from oriental medicines, inhibits mammalianlipoxygenases. Biochem. Pharmacol. 48 (1994) 1979–1981.10.1016/0006-2952(94)90598-3Suche in Google Scholar

5. Metzger, B. T.; Barnes, D. M.; Reed, J. D.: Purple Carrot (Daucus carota L.) polyacetylenes decrease lipopolysaccharide-induced expression of inflammatory proteins in macrophage and endothelial cells. J. Agric. Food Chem. 56 (2008) 3554–3560.10.1021/jf073494tSuche in Google Scholar PubMed

6. Resch, M.; Heilmann, J.; Steigel, A.: Further phenols and polyacetylenes from the rhizomes of Atractylodes lancea and their anti-inflammatory activity. Planta Med. 67 (2001) 437–439.10.1055/s-2001-15817Suche in Google Scholar PubMed

7. Yang, M. C.; Kwon, H. C.; Kim, Y.-J.; Lee, K. R.; Yang, H. O.: Oploxynes A and B, polyacetylenes from the stems of Oplopanax elatus. J. Nat. Prod. 73 (2010) 801–805.10.1021/np900628jSuche in Google Scholar PubMed

8. Hong, S. S.; Lee, J. H.; Jeong, W.; Kim, N.; Jin, H. Z.; Hwang, B. Y.; Lee, H.-J.; Lee, S.-J.; Jang, D. S.; Lee, D.: Acetylenic acid analogues from the edible mushroom Chanterelle (Cantharellus cibarius) and their effects on the gene expression of peroxisome proliferator-activated receptor-gamma target genes. Bioorg. Med. Chem. Lett. 22 (2012) 2347–2349.10.1016/j.bmcl.2012.01.070Suche in Google Scholar PubMed

9. Zhang, S. L.; Deng, Z. Q.: Synthesis of quinolines and naphthyridines via catalytic retro-aldol reaction of β–hydroxyketones with ortho-aminobenzaldehydes or nicotinaldehydes. Org. Biomol. Chem. 14 (2016) 8966–8970.10.1039/C6OB01452FSuche in Google Scholar PubMed

10. Chen, X. M.; Zhang, X. Y.; He, F. L.; Pan, J.; Jia, G.-K.: Crystal structure of (2E,4Z)-dimethyl-4-((phenylamino)methylene)pent-2-enedioate, C14H15O4N. Z. Kristallogr. NCS 234 (2019) 87–89.10.1515/ncrs-2018-0194Suche in Google Scholar

11. D’Souza, D. M.; Kiel, A.; Herten, D.-P.; Rominger, F.; Muller, T. J. J.: Synthesis, structure and emission properties of spirocyclic benzofuranones and dihydroindolones: a domino insertion–coupling–isomerization–diels–alder approach to rigid fluorophores. Chem. Eur. J. 14 (2008) 529–547.10.1002/chem.200700759Suche in Google Scholar PubMed

12. Lellek, V.; Hansen, H.-J.: Unexpected thermal transformation of aryl 3-arylprop-2-ynoates: formation of 3-(diarylmethylidene)-2,3-dihydrofuran-2-ones. Helv. Chim. Acta 84 (2001) 3548–3580.10.1002/1522-2675(20011219)84:12<3548::AID-HLCA3548>3.0.CO;2-2Suche in Google Scholar

Received: 2019-04-17
Accepted: 2019-06-20
Published Online: 2019-09-09
Published in Print: 2019-11-26

©2019 Jun Pan et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 Public License.

Artikel in diesem Heft

  1. Frontmatter
  2. Crystal structure of [aqua[2,2′-(1,2-phenylene)bis(1H-imidazole-4-carboxylato-5-carboxy)-κ4N3,N3,O4,O4] zinc(II)] monohydrate, C16H10N4O9Zn⋅H2O
  3. Crystal structure of ethyl 3-(4-methoxyphenyl)-5-methylcarbamoyl-1H-pyrazole-4-carboxylate, C15H17N3O4
  4. 7-(4-Fluorobenzylidene)-3-(4-fluorophenyl)-N-phenyl-3,3a,4,5,6,7-hexahydro-2H-indazole-2-carbothioamide–dimethylformamide (2/1), C27H23F2N3S, 0.5(C3H7NO)
  5. Crystal structure of 4,4′-(hydrazonomethylene)diphenol dihydrate, C13H16N2O4
  6. Crystal structure of 4-methoxyphenyl-3-phenylpropiolate, C16H12O3
  7. Crystal Structure of tris(tetrakis{1-vinyl-1H-imidazole-κN}copper(II)) bis[tri-μ2-bromido-tetrabromido-bis(1-vinyl-1H-imidazole-κN)tetracopper(I)], C80H96N32Cu11Br14
  8. Crystal structure of (E)-2-(3,6-bis(diethylamino)-9H-xanthen-9-yl)-N′-(quinoxalin-2-ylmethylene)benzohydrazide, C37H36N6O2
  9. Crystal structure of 4-(1-phenylimidazo[1,5-a]pyridin-3-yl)benzoic acid (C20H14N2O2)
  10. Crystal structure of 3-fluoro-3-methyl-1-((2-nitrophenyl)sulfonyl)-5,5-diphenylpiperidine, C24H23FN2O4S
  11. Crystal structure of dimethyl 3,12-dibenzyl-6,10-diphenyl-3,12-diazapentacyclo [6.3.1.02.7.04.11.05.9]-dodecane-7,11-dicarboxylate — acetone (2/1), C40H38N2O2 ⋅ 0.5C3H6O
  12. Crystal structure of poly[(μ2-2-(1H-1,2,4-triazol-1-yl)benzoato-κ4O:O′:N:N′)silver(I)] monohydrate, C9H8AgO3N3
  13. Crystal structure of poly[(μ2-9H-carbazole-3,6-dicarboxylate-κ4O1,O2:O3,O4)(μ2-1,3-di(pyridin-4-yl)propane-κ2N:N)cadmium(II)]monohydrate, C27H23N3O5Cd
  14. The synthesis and crystal structure of bis(2-(benzo[d]thiazol-2-yl)-5-methylbenzen-1-ido-κ2C,N)-(N,N′-diethyldithiocarbamato-κ2S,S′)iridium(III), C33H30N3S4Ir
  15. The crystal structure of 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(trifluoromethylsulfonyl)-1H-pyrazole-3-carboxamide, C12H6N4Cl2F6O3S
  16. Synthesis and crystal structure of poly[(μ2-nitrato-κ4O,O′:O′,O′′)-nitrato-κO-(μ2-1,4-bis((1H-imidazol-1-yl)methyl)benzene-κ2N:N′)cadmium(II)], C14H14N6O6Cd
  17. Crystal structure of ethyl (Z)-(4-oxo-4-phenylbut-2-en-2-yl)glycinate, C14H17NO3
  18. Halogen bonds in the crystal structure of 5-bromo-3,4′-bipyridine – 1,4-diiodotetrafluorobenzene (2/1), C26H14Br2F4I2N4
  19. Crystal structure of bis(2,2′-bipyridine-κ2N,N′)-tetrakis(μ2-3-(phenylsulfonamido)propanoato-κ2O:O′)-bis(3-(phenylsulfonamido)propanoato-κ2O,O′)digadolinium(III) – 2,2′-bipyridine (1/1), C84H84Gd2N12O24S6
  20. Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ2O:O′)bis(μ2-pyrazin-κ2N:N′)silver(I)], C14H16Ag2N5O8S2
  21. The crystal structure of 1,6-di-tert-butyl-1,1,3,3,4,4,6,6-octamethyl-2,2,5,5-tetrakis (trimethylsilyl)hexasilane, C28H78Si10
  22. Crystal structure of discandium triruthenium tetrasilicide, Sc2Ru3Si4
  23. Crystal structure of poly[(μ2-4-amino-1,5-naphthalenedisulfonato-κ4O,N:O′, N′)bis(μ2-hexamethylenetetramino-κ2N;N′)silver(I)], {C22H30Ag2N9O6S2}n
  24. Crystal structure of diaqua[5,5′-dicarboxy-2,2′-(propane-1,3-diyl)bis(1H-imidazole-4-carboxylato-κ4O,O′,N,N′)]zinc(II) dihydrate, C13H18N4O12Zn
  25. The crystal structure of poly [(μ3-N1,N4-bis(pyridin-3-yl)cyclohexane-1,4-dicarboxamide-κ3-O:N:N′)-(p-toluenesulfonato-κ2O,O′)silver(I)], C25H27Ag1N4O5S
  26. The crystal structure of 1,2-bis(3-bromophenoxy) ethane, C14H12Br2O2
  27. The crystal structure of 4-(pyren-1-yl)butyl-3-nitrobenzoate, C27H21NO4
  28. Crystal structure of bis[(2-(4-chlorophenyl)-5-methyl-1,3-dioxane-5-carboxylato-κ1O) (5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)]nickel(II), C40H60Cl2N4NiO8
  29. The crystal structure of 1,5-dinitro-2,3,4-trichlorobenzene, C6H1Cl3N2O4
  30. The crystal structure of the solid solution of 3,5-dinitropyrazole and 4-chlorine-3,5-dinitropyrazole, C3H1.24Cl0.76N4O4
  31. The cocrystal structure of 4-nitropyrazole — acetic acid (1/1), C5H7N3O4
  32. The crystal structure of propan-2-one O-(2,4,6-trinitrophenyl) oxime, C9H8N4O7
  33. The crystal structure of ethyl 2-(3-(2-ethoxy-2-oxoethyl)benzo[d] thiazol-2(3H)-ylidene)acetate, C15H17NO4S
  34. Crystal structure of (acetic acid-κ1O)-bis(μ2-2-chlorobenzoato-κ2O:O′)-(2-chlorobenzoato-κ1O)-(μ2-hydroxy-κ2O:O)-bis(1,10-phenanthroline-κ2N,N′)dimanganese(II) — methanol (1/1), C48H37Cl3Mn2N4O10
  35. Crystal structure of 3-methyl-2-phenyl-1,8-naphthyridine, C15H12N2
  36. Crystal structure of chlorido-(5-acetyl-2-(5-methylpyridin-2-yl)benzen-1-ido-κ2C,N)-pyridine-κN-palladium(II), C19H17ClN2OPd
  37. Crystal structure of (4-methyl-benzoato-κ2O,O′)-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′)nickel(II) perchlorate monohydrate, C24H45ClN4NiO7
  38. Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6) 1,2,3,4,5-pentamethyl-cyclopenta-2,4-dien-1-yl(potassium, rubidium) — ammonia (1/2), [K0.3Rb0.7(18-crown-6)]Cp*⋅2 NH3, C22H45K0.3N2O6Rb0.7
  39. Crystal structure of (3E,5E)-1-((4-fluorophenyl)sulfonyl)-3,5-bis(3-nitrobenzylidene)piperidin-4-one — dichloromethane (2/1), C51H38Cl2F2N6O14S2
  40. Crystal structure of (E)-N′-((1,6-dihydropyren-1-yl)methylene)isonicotinohydrazide — methanol (1/1), C24H19N3O2
  41. Crystal structure of poly[aqua(μ2-2-amino-1,4-benzenedisulfonato-κ3N,O:O′)-(μ4-hexamethylenetetramino-κ4N:N′:N′′:N′′′)disilver(I)] monohydrate, C12H21Ag2N5O8S2
  42. Crystal structure of bis(acridin-10-ium) 2,5-dihydroxyterephthalate — 2,5-dihydroxyterephthalic acid (1/1), C21H15NO6
  43. The crystal structure of 1,12-diazaperylene, C18H10N2
  44. Crystal structure of 1-(5-(4-chlorophenyl)-3-(2-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethan-1-one, C17H14N2OFCl
  45. Crystal structure of (4aR,6aR,6bR,10S,12aR)-10-acetoxy-1,2,3,4, 4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a, 12b,13,14b-icosahydro-2,2,4a,6b,9,9,12a-heptamethylpicene-6a-carboxylic acid, C32H50O4
  46. The crystal structure of tetrachlorido-bis{1,3-bis(2,6-diisopropylphenyl)-1H-3λ4-imidazol-2-yl}-(μ2-pyrimidine-κ2N:N′)dipalladium(IV) — dichloromethane (1/2), C60H80Cl8N6Pd2
  47. The crystal structure of (E)-4-(7-methoxy-2-oxo-2H-chromen-8-yl)-2-methylbut-2-en-1-yl 4-nitrobenzoate, C22H19NO7
  48. Crystal structure of 3-methyl-N-(pyrimidin-5-ylmethyl)pyridin-2-amine, C11H12N4
  49. The crystal structure of 2,5-dichloroterephthalic acid dihydrate, C8H8Cl2O6
  50. The crystal structure of 2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine — dimethylformamide (1/1), C33H28N10O
  51. Crystal structure of N-(adamantan-1-yl)-5-(dimethylamino)naphthalene-1-sulfonamide, C22H28N2O2S
  52. Crystal structure of poly[diaqua-(μ4-4-(3,5-dicarboxy-κ1O-phenoxy)phthalato-κ3O:O′:O′)cadmium(II)], C16H12CdO11
  53. Crystal structure of poly[diaqua-bis(μ2-3-((1H-imidazol-1-yl)methyl)benzoato-κ2N:O)manganese(II)], C22H22MnN4O6
  54. Crystal structure of 9-(3-phenoxyphenyl)-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione, C25H23NO3
  55. The crystal structure of poly[(μ3-2,4,6-tris[4-(1H-imidazol-1-yl)phenyl]-1,3,5-triazine-k3N:N′:N′′)-(nitrato-k2O,O)-(nitrato-k1O)zinc(II)] - N,N-dimethylacetamide (1/2), C38H39N13O8Zn
  56. Crystal structure of poly[(μ7-4-(3,5-dicarboxylatophenoxy)phthalato)-(1,10-phenanthroline-κ2N,N′)dizinc(II)], C28H14N2O9Zn2
  57. The crystal structure of methyl 2-(benzylamino)-5-(benzyloxy)benzoate, C22H21NO3
  58. Crystal structure of (1,4,8,11-tetraazacyclotetradecane)palladium(II) tetracyanoplatinate(II), C14H24N8PdPt
  59. Crystal structure of (pyridine-2-carboxylato-κ2N,O)-[2-(2-pyridyl)phenyl-κ2N,C1]palladium(II), C17H12N2O2Pd
  60. Crystal structure of (cyclohexane-1,4-diammonium) 4-[(4-carboxylatophenyl)disulfanyl]benzoate dimethylsulphoxide hydrate (1/1/1/1), [C6H16N2]2+[C14H8O4S2]2−⋅C2H6OS⋅H2O
  61. Crystal structure of the 2:1 co-crystal 2-[(2-carboxyphenyl)disulfanyl]benzoic acid – 3-bromobenzoic acid, 2(C14H10O4S2)⋅C7H5BrO2
  62. Crystal structure of chlorido-dimethyl-(phenylpiperazine-1-carbodithioato-κ2S,S′)tin(IV), C13H19ClN2S2Sn
  63. Crystal structure of (N-n-butyl, N-methyl-dithiocarbamato-κ2 S,S′)-chlorido-dimethyl-tin(IV), C8H18ClNS2Sn
  64. Crystal structure of (2,2′-bipyridyl)bis(4-bromobenzyl)dibromidotin(IV), C24H20Br4N2Sn
  65. Crystal structure of (2,2′-bipyridyl)bis(4-chlorobenzyl)dichloridotin(IV), C24H20Cl4N2Sn
  66. Crystal structure of N-methyl-N-phenyl(methylsulfanyl)carbothioamide, C9H11NS2
  67. Crystal structure of 4-phenylpiperazin-1-ium (4-phenylpiperazin-1-yl)carbothioylsulfanide, [C10H15N2][C11H13N2S2]
  68. Crystal structure of catena-{di-aqua-sodium [n-butyl(methyl)carbamothioyl]sulfanide}n, [C6H16NNaO2S2]n
  69. Crystal structure of (2-([1,1-bis(hydroxymethyl)-2-oxyethyl]iminomethyl)-5-(n-decyl)phenolato)-dimethyl-tin(IV), C23H39NO5Sn
  70. Crystal structure of 4-chloro-N′-[(1E)-(3-ethoxy-2-hydroxyphenyl)methylidene]benzohydrazide – a Z′ = 3 structure, C16H15ClN2O3
Heruntergeladen am 17.11.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2019-0279/html
Button zum nach oben scrollen